Wilhelm Krek

19.5k total citations · 3 hit papers
93 papers, 10.8k citations indexed

About

Wilhelm Krek is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Wilhelm Krek has authored 93 papers receiving a total of 10.8k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Molecular Biology, 29 papers in Cancer Research and 26 papers in Oncology. Recurrent topics in Wilhelm Krek's work include Cancer, Hypoxia, and Metabolism (21 papers), Cancer-related Molecular Pathways (20 papers) and Microtubule and mitosis dynamics (14 papers). Wilhelm Krek is often cited by papers focused on Cancer, Hypoxia, and Metabolism (21 papers), Cancer-related Molecular Pathways (20 papers) and Microtubule and mitosis dynamics (14 papers). Wilhelm Krek collaborates with scholars based in Switzerland, United States and Germany. Wilhelm Krek's co-authors include Erich A. Nigg, Holger Moch, Joanna Lisztwan, Claudio R. Thoma, C Wirbelauer, Ian J. Frew, James A. DeCaprio, Matthias Gstaiger, David M. Livingston and Edward J. Oakeley and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Wilhelm Krek

92 papers receiving 10.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties

1992 777 citations Wilhelm Krek, James A. DeCaprio et al. profile →
Chemokine receptor CXCR4 downregulated by von Hippel–Lindau tumour suppressor pVHL

2003 693 citations Joanna Lisztwan, Holger Moch et al. profile →
3D cell culture systems modeling tumor growth determinants in cancer target discovery

2014 382 citations Claudio R. Thoma, Miriam Zimmermann et al. Advanced Drug Delivery Reviews profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wilhelm Krek Switzerland	52	7.6k	3.7k	2.3k	1.7k	1.4k	93	10.8k
Alfonso Bellacosa United States	52	10.8k 1.4×	4.0k 1.1×	2.3k 1.0×	1.1k 0.6×	1.1k 0.8×	118	14.4k
Rolf Bjerkvig Norway	59	6.3k 0.8×	3.4k 0.9×	3.3k 1.4×	1.5k 0.8×	685 0.5×	235	12.7k
Lewis A. Chodosh United States	61	9.6k 1.3×	4.4k 1.2×	3.1k 1.3×	1.3k 0.7×	2.8k 2.0×	153	14.4k
Onno Kranenburg Netherlands	52	5.4k 0.7×	3.0k 0.8×	1.5k 0.7×	1.5k 0.9×	1.0k 0.7×	188	9.8k
Jiřina Bártková Denmark	62	10.5k 1.4×	7.8k 2.1×	2.8k 1.2×	2.0k 1.1×	1.8k 1.3×	136	15.4k
Patrice J. Morin United States	50	11.7k 1.5×	3.8k 1.0×	3.4k 1.5×	1.4k 0.8×	1.6k 1.2×	82	16.8k
Laura D. Attardi United States	48	9.4k 1.2×	4.3k 1.2×	3.9k 1.7×	920 0.5×	730 0.5×	104	12.4k
Hui‐Kuan Lin United States	53	7.6k 1.0×	2.3k 0.6×	2.4k 1.0×	931 0.5×	1.0k 0.7×	120	10.7k
Bořivoj Vojtěšek Czechia	53	6.4k 0.8×	5.0k 1.3×	1.7k 0.7×	1.2k 0.7×	617 0.4×	314	10.8k
David Stokoe United States	53	11.5k 1.5×	3.5k 1.0×	2.5k 1.1×	1.6k 0.9×	714 0.5×	96	15.7k

Countries citing papers authored by Wilhelm Krek

Since Specialization

Citations

This map shows the geographic impact of Wilhelm Krek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wilhelm Krek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wilhelm Krek more than expected).

Fields of papers citing papers by Wilhelm Krek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wilhelm Krek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wilhelm Krek. The network helps show where Wilhelm Krek may publish in the future.

Co-authorship network of co-authors of Wilhelm Krek

This figure shows the co-authorship network connecting the top 25 collaborators of Wilhelm Krek. A scholar is included among the top collaborators of Wilhelm Krek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wilhelm Krek. Wilhelm Krek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Markolin, Philipp, Natalie R. Davidson, Christian Hirt, et al.. (2021). Identification of HIF-dependent alternative splicing in gastrointestinal cancers and characterization of a long, coding isoform of SLC35A3. Genomics. 113(2). 515–529. 4 indexed citations

Mirtschink, Peter & Wilhelm Krek. (2016). Hypoxia-driven glycolytic and fructolytic metabolic programs: Pivotal to hypertrophic heart disease. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1863(7). 1822–1828. 46 indexed citations

Schönenberger, Miriam J., Wilhelm Krek, & Werner J. Kovacs. (2015). EPAS1/HIF-2α is a driver of mammalian pexophagy. Autophagy. 11(6). 967–969. 17 indexed citations

Thoma, Claudio R., et al.. (2014). miR-28-5p Promotes Chromosomal Instability in VHL -Associated Cancers by Inhibiting Mad2 Translation. Cancer Research. 74(9). 2432–2443. 42 indexed citations

Thoma, Claudio R., Miriam Zimmermann, Irina Agarkova, Jens M. Kelm, & Wilhelm Krek. (2014). 3D cell culture systems modeling tumor growth determinants in cancer target discovery. Advanced Drug Delivery Reviews. 69-70. 29–41. 382 indexed citations breakdown →

Thoma, Claudio R., Kathryn T. Applegate, Maria Duda, et al.. (2013). Tumor Suppressor NF2/Merlin Is a Microtubule Stabilizer. Cancer Research. 74(1). 353–362. 16 indexed citations

Duda, Maria, et al.. (2013). Tumor Suppressor VHL Functions in the Control of Mitotic Fidelity. Cancer Research. 74(9). 2422–2431. 27 indexed citations

Casagrande, Silvia, Markus Rechsteiner, Laura Morra, et al.. (2012). The protein tyrosine phosphatase receptor type J is regulated by the pVHL–HIF axis in clear cell renal cell carcinoma. The Journal of Pathology. 229(4). 525–534. 9 indexed citations

Wild, Peter J., Kristian Ikenberg, Thomas J. Fuchs, et al.. (2012). p53 suppresses type II endometrial carcinomas in mice and governs endometrial tumour aggressiveness in humans. EMBO Molecular Medicine. 4(8). 808–824. 52 indexed citations

10.

Krishnan, Jaya, Carsten Friedrich Danzer, Jozef Ukropec, et al.. (2012). Dietary obesity-associated Hif1α activation in adipocytes restricts fatty acid oxidation and energy expenditure via suppression of the Sirt2-NAD⁺ system. Genes & Development. 26(3). 259–270. 262 indexed citations

11.

Thoma, Clemens, Alberto Toso, Patrick Meraldi, & Wilhelm Krek. (2011). Mechanisms of aneuploidy and its suppression by tumour suppressor proteins. Swiss Medical Weekly. 141(910). w13170–w13170. 8 indexed citations

12.

Ye, Qiong, Carsten Friedrich Danzer, Alexander Fuchs, et al.. (2011). Longitudinal evaluation of intramyocellular lipids (IMCLs) in tibialis anterior muscle of ob/ob and ob/+ control mice using a cryogenic surface coil at 9.4 T. NMR in Biomedicine. 24(10). 1295–1301. 6 indexed citations

13.

Frew, Ian J., Andrea Minola, Strahil Georgiev, et al.. (2008). Combined Vhlh and Pten Mutation Causes Genital Tract Cystadenoma and Squamous Metaplasia. Molecular and Cellular Biology. 28(14). 4536–4548. 38 indexed citations

14.

Djouder, Nabil, Alexander Schmidt, C Wirbelauer, et al.. (2007). S6K1-Mediated Disassembly of Mitochondrial URI/PP1γ Complexes Activates a Negative Feedback Program that Counters S6K1 Survival Signaling. Molecular Cell. 28(1). 28–40. 91 indexed citations

15.

Yart, Armelle, Matthias Gstaiger, C Wirbelauer, et al.. (2005). The HRPT2 Tumor Suppressor Gene Product Parafibromin Associates with Human PAF1 and RNA Polymerase II. Molecular and Cellular Biology. 25(12). 5052–5060. 155 indexed citations

16.

Koziczak, Magdalena, Wilhelm Krek, & Yoshikuni Nagamine. (2000). Pocket Protein-Independent Repression of Urokinase-Type Plasminogen Activator and Plasminogen Activator Inhibitor 1 Gene Expression by E2F1. Molecular and Cellular Biology. 20(6). 2014–2022. 41 indexed citations

17.

Lisztwan, Joanna, et al.. (1999). The von Hippel-Lindau tumor suppressor protein is a component of an E3 ubiquitin-protein ligase activity. Genes & Development. 13(14). 1822–1833. 320 indexed citations

18.

Wirbelauer, C, et al.. (1999). Increased levels of E2F-1-dependent DNA binding activity after UV- or -irradiation. Nucleic Acids Research. 27(2). 491–495. 58 indexed citations

19.

Krek, Wilhelm & James A. DeCaprio. (1995). [7] Cell synchronization. Methods in enzymology on CD-ROM/Methods in enzymology. 254. 114–124. 179 indexed citations

20.

Nigg, Erich A., Wilhelm Krek, & Matthias Peter. (1991). Vertebrate cdc2 Kinase: Its Regulation by Phosphorylation and Its Mitotic Targets. Cold Spring Harbor Symposia on Quantitative Biology. 56(0). 539–547. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact